Ablation of Discoidin Domain Receptor 1 Provokes an Osteopenic Phenotype by Regulating Osteoblast/Osteocyte Autophagy and Apoptosis.
Hsin-Chiao ChouSung-Yen LinLiang-Yin ChouMei-Ling HoShu-Chun ChuangTsung-Lin ChengLin KangYi-Shan LinYan-Hsiung WangChun-Wang WeiChung-Hwan ChenChau-Zen WangPublished in: Biomedicines (2022)
Discoidin domain receptor 1 (DDR1) is a collagen receptor that belongs to the receptor tyrosine kinase family. We have previously shown that DDR1 plays a crucial role during bone development, resulting in dwarfism and a short stature in osteoblast-specific knockout mice (OKO mice). However, the detailed pathophysiological effects of DDR1 on bone development throughout adulthood have remained unclear. This study aims to identify how DDR1 regulates osteoblast and osteocyte functions in vivo and in vitro during bone development in adulthood. The metabolic changes in bone tissues were analyzed using Micro-CT and immunohistochemistry staining (IHC) in vivo; the role of DDR1 in regulating osteoblasts was examined in MC3T3-E1 cells in vitro. The Micro-CT analysis results demonstrated that OKO mice showed a 10% reduction in bone-related parameters from 10 to 14 weeks old and a significant reduction in cortical thickness and diameter compared with flox/flox control mice (FF) mice. These results indicated that DDR1 knockout in OKO mice exhibiting significant bone loss provokes an osteopenic phenotype. The IHC staining revealed a significant decrease in osteogenesis-related genes, including RUNX2, osteocalcin, and osterix. We noted that DDR1 knockout significantly induced osteoblast/osteocyte apoptosis and markedly decreased autophagy activity in vivo. Additionally, the results of the gain- and loss-of-function of the DDR1 assay in MC3T3-E1 cells indicated that DDR1 can regulate the osteoblast differentiation through activating autophagy by regulating the phosphorylation of the mechanistic target of rapamycin (p-mTOR), light chain 3 (LC3), and beclin-1. In conclusion, our study highlights that the ablation of DDR1 results in cancellous bone loss by regulating osteoblast/osteocyte autophagy. These results suggest that DDR1 can act as a potential therapeutic target for managing cancellous bone loss.
Keyphrases
- bone loss
- bone regeneration
- endoplasmic reticulum stress
- cell death
- cell cycle arrest
- induced apoptosis
- oxidative stress
- tyrosine kinase
- high fat diet induced
- signaling pathway
- bone mineral density
- wild type
- depressive symptoms
- computed tomography
- epidermal growth factor receptor
- soft tissue
- magnetic resonance imaging
- gene expression
- pi k akt
- postmenopausal women
- image quality
- cell proliferation
- diabetic rats
- binding protein
- risk assessment
- dual energy
- optical coherence tomography
- endothelial cells
- protein kinase
- liquid chromatography
- skeletal muscle